Clinical Omics

In this article, we explore multiomic approaches to COVID-19 research and explore some of the computational and statistical tools being developed to support multiomic analyses.

Download this list to discover more about the latest research in clinical Omics, including how these fields are revolutionizing diagnostics, disease prediction and treatment strategies.

Due to its broad-based applicability to detect compounds with a wide range of masses, along with its high sensitivity, mass spectrometry (MS) has been used extensively in a range of omics analyses and applications. In this listicle, we explore the use of MS-based data in a variety of clinical omics settings.

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.